LEXX – lexaria bioscience corp. (US:NASDAQ)
Stock Stats
News
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]
Lexaria Bioscience (NASDAQ:LEXX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Lexaria Bioscience (NASDAQ:LEXX) was downgraded by analysts at Wall Stre
Form 8-K Lexaria Bioscience Corp. For: Jan 27
Form S-8 Lexaria Bioscience Corp.
Form EFFECT Lexaria Bioscience Corp.
Form 424B3 Lexaria Bioscience Corp.
Form 25-NSE Lexaria Bioscience Corp. Filed by: Nasdaq Stock Market LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.